跳至主要内容
临床试验/NCT00549952
NCT00549952Unknown不适用

Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients

Korea Otsuka Pharmaceutical Co., Ltd.1 个研究点 分布在 1 个国家开始时间: 2007年10月最近更新:
适应症

试验速览

阶段
不适用
试验地点
1
主要终点
incidence and severity of oral mucositis

研究概览

简要总结

to survey oral mucositis after chemotherapy and Concurrent chemoradiotherapy in Korean cancer patients

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with one cancer among head and neck cancer, esophageal cancer, breast cancer, colorectal cancer, gastric cancer, and non-small cell lung cancer, who are being treated or going to be treated as one between A and B A. Chemotherapy only B. Concurrent chemoradiotherapy

排除标准

  • Patients who are pregnant or breast feeding, absent from effective(medically proven) contraceptive method for females of childbearing potential
  • Patients with performance status of ECOG score is more than 3

结局指标

主要结局

incidence and severity of oral mucositis

次要结局

未报告次要终点

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验